 | This article's factual accuracy may be compromised due to out-of-date information.(August 2013) |
| This article's factual accuracy may be compromised due to out-of-date information.(August 2013) |
| Medication | Trade name | Primary Indication | Company | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 [1] [2] [3] [4] [5] [6] | 2007 [7] [8] [9] [10] [11] [12] | 2006 [13] [14] [15] [16] [17] [18] | 2005 [19] [20] [21] [22] [23] | 2004 [24] [25] [26] [27] | 2003 [28] [29] [30] [31] | 2002 [32] [33] [34] [35] | 2001 [36] | 2000 [37] [38] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| atorvastatin | Lipitor | Reduction of LDL cholesterol | Pfizer | $12,401 | $12,675 | $12,886 | $12,187 | $10,862 | $9,231 | $7,972 | $6,448 | $5,028 | |||||||
| sunitinib malate | Sutent | Advanced and/or metastatic renal cell carcinoma (mRCC) & refractory gastrointestinal stromal tumors (GIST) | Pfizer | $847 | $581 | $219 | |||||||||||||
| irinotecan | Camptosar | Metastatic colorectal cancer | Pfizer | $563 | $969 | $903 | $910 | $554 | $299 | ||||||||||
| bimatoprost | Lumigan | Open-angle glaucoma or ocular hypertension | Allergan | $426.2 | $391.7 | $327.5 | $267.6 | $232.9 | $181.3 | $123 | $35.4 | ||||||||
| exemestane | Aromasin | Breast cancer | Pfizer | $465 | $401 | $320 | $247 | $143 | $58 | ||||||||||
| epirubicin | Ellence | Breast cancer | Pfizer | $312 | $367 | $344 | $216 | ||||||||||||
| trastuzumab | Herceptin | HER2-positive metastatic breast cancer | Genentech | $1,382 | $1,287 | $1,234 | $747.2 | $483.2 | $424.8 | $385.2 | $346.7 | $276 | |||||||
| gemcitabine | Gemzar | Ovarian cancer, non-small cell lung cancer (NSCLC), metastatic breast cancer (MBC), and pancreatic cancer | Eli Lilly & Co. | $1,719.8 | $1,592.4 | $1,408.1 | $1,334.5 | $1,214.4 | $1,021.7 | $875 | $723 | $559.3 | |||||||
| bevacizumab | Avastin | Metastatic colorectal cancer, non-small cell lung cancer (NSCLC), renal cell carcinoma, HER2-negative breast cancer | Genentech | $2,686 | $2,296 | $1,746 | $1,132 | $554.6 | |||||||||||
| erlotinib | Tarceva | Advanced (metastatic) non-small cell lung cancer (NSCLC) | Genentech | $457 | $417 | $402 | $274.9 | $13.3 | |||||||||||
| brimonidine | Alphagan | Open-angle glaucoma or ocular hypertension | Allergan | $286.8 | $248.5 | $250.9 | |||||||||||||
| rituximab | Rituxan | Non-Hodgkin's lymphoma and rheumatoid arthritis | Genentech | $2,587 | $2,285 | $2,071 | $1,831.4 | $1,574 | $1,360.2 | $1,162.9 | $818.6 | ||||||||
| ranibizumab | Lucentis | Age-related macular degeneration (AMD) | Genentech | $875 | $815 | $380 | |||||||||||||
| omalizumab | Xolair | Asthma | Genentech | $517 | $472 | $425 | $320.6 | $187.6 | $25.1 | ||||||||||
| somatropin | Nutropin | Growth hormone deficiency, chronic kidney disease | Genentech | $358 | $371 | $378 | $370.5 | $348.8 | $319.5 | ||||||||||
| dornase alfa | Pulmozyme | Cystic fibrosis (CF) | Genentech | $257 | $223 | $199 | $186.5 | $157.1 | $143.7 | $138.1 | $123 | ||||||||
| efalizumab | Raptiva | Plaque psoriasis | Genentech | $108 | $107 | $90 | $79.2 | $52.4 | $1.4 | ||||||||||
| montelukast | Singulair | Asthma | Merck | $4,336.9 | $4,266.3 | $3,579 | $2,975.6 | $2,622 | |||||||||||
| alendronate sodium | Fosamax | Postmenopausal osteoporosis | Merck | $1,552.7 | $3,049 | $3,134.4 | $3,191.2 | $3,159.7 | |||||||||||
| sitagliptin | Januvia | Type 2 diabetes | Merck | $1,397.1 | $667.5 | $42.9 | |||||||||||||
| simvastatin | Zocor | Reduction of LDL cholesterol | Merck | $660.1 | $876.5 | $2,802.7 | $4,381.7 | $5,196.5 | |||||||||||
| rizatriptan benzoate | Maxalt | Migraine pain | Merck | $529.2 | $467.3 | $406.4 | $348.4 | $309.9 | |||||||||||
| finasteride | Propecia | Hair loss | Merck | $429.1 | $405.4 | $351.8 | $291.9 | $270.2 | |||||||||||
| etoricoxib | Arcoxia | Osteoarthritis and rheumatoid arthritis | Merck | $377.3 | $329.1 | $265.4 | $218.2 | ||||||||||||
| sitagliptin/metformin HCl | Janumet | Type 2 diabetes | Merck | $351.1 | $86.4 | ||||||||||||||
| finasteride | Proscar | Benign prostatic hyperplasia (enlarged prostate) | Merck | $323.5 | $411 | $618.5 | $741.4 | $733.1 | |||||||||||
| aprepitant | Emend | Nausea and vomiting prevention caused by chemotherapy | Merck | $263.8 | $204.2 | $130.8 | $87 | ||||||||||||
| olanzapine | Zyprexa | Schizophrenia | Eli Lilly & Co. | $4,696.1 | $4,761 | $4,363.6 | $4,202.3 | $4,419.8 | $4,276.9 | $3,689 | $3,087 | $2,349.5 | |||||||
| duloxetine HCl | Cymbalta | Depression and generalized anxiety disorder | Eli Lilly & Co. | $2,697.1 | $2,102.9 | $1,316.4 | $679.7 | $93.9 | |||||||||||
| insulin lispro | Humalog | Type 1 diabetes in adults | Eli Lilly & Co. | $1,735.8 | $1,474.6 | $1,299.5 | $1,197.7 | $1,101.6 | $1,021.3 | $834 | $628 | $350.2 | |||||||
| pemetrexed | Alimta | Locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) | Eli Lilly & Co. | $1,154.7 | $854 | $611.8 | $463.2 | $142.6 | |||||||||||
| raloxifene HCl | Evista | Osteoporosis | Eli Lilly & Co. | $1,075.6 | $1,090.7 | $1,045.3 | $1,036.1 | $1,012.7 | $922.1 | $822 | $665 | $521.5 | |||||||
| insulin isophane | Humulin | Diabetes | Eli Lilly & Co. | $1,063.2 | $985.2 | $925.3 | $1,004.7 | $997.7 | $1,060.4 | $1,004 | $1,061 | $1,114.5 | |||||||
| teriparatide | Forteo | Osteoporosis | Eli Lilly & Co. | $778.7 | $709.3 | $594.3 | $389.3 | $238.6 | $65.3 | ||||||||||
| atomoxetine HCl | Strattera | Attention-deficit/hyperactivity disorder (ADHD) | Eli Lilly & Co. | $579.5 | $569.4 | $579 | $552.1 | $666.7 | $370.3 | ||||||||||
| timolol | Istalol | Open-angle glaucoma | Ista Pharmaceutical | $14.6 | $11.3 | $8.3 | $2.6 | ||||||||||||
| bromfenac | Xibrom | Ocular inflammation | Ista Pharmaceutical | $63 | $42.1 | $20.2 | $5.3 | ||||||||||||
| hyaluronidase | Vitrase | Spreading agent | Ista Pharmaceutica | $5.2 | $5.2 | $4.2 | $2.5 | ||||||||||||
| rivaroxaban | Xarelto | Deep vein thrombosis | Johnson & Johnson [39] | $1,868 | $1,522 | $864 | $239 | $25 |
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.
Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy using drug testing and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Icos Corporation was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it was sold to Eli Lilly and Company in 2007. It was founded in 1989 by David Blech, Isaac Blech, Robert Nowinski, and George Rathmann, a pioneer in the industry and chief executive officer (CEO) and co-founder of Amgen, Icos focused on the development of drugs to treat inflammatory disorders. During its 17-year history, the company conducted clinical trials of twelve drugs, three of which reached the last phase of clinical trials. Icos also manufactured antibodies for other biotechnology companies.
DOV Pharmaceutical was a biotechnology company that focused on therapies primarily for central nervous system conditions. It was founded in 1995 by former employees of American Cyanamid, and in 1998 it in-licensed drugs discovered at American Cyanamid for further development. It held an IPO on NASDQ in 2002, and its shares plunged days later after negative details about a past relationship between Élan and DOV emerged.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
The ethics involved within pharmaceutical sales is built from the organizational ethics, which is a matter of system compliance, accountability and culture. Organizational ethics are used when developing the marketing and sales strategy to both the public and the healthcare profession of the strategy. Organizational ethics are best demonstrated through acts of fairness, compassion, integrity, honor, and responsibility.
Bepotastine is a 2nd generation antihistamine. It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. It is currently marketed in the United States as an eye drop under the brand-name Bepreve, by ISTA Pharmaceuticals, a subsidiary of Bausch + Lomb.
The National Health Council (NHC) is a nonprofit association of health organizations.
AMRI is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded in 1991, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.
The Piramal Group is an Indian multinational diversified global business conglomerate, that has presence across various sectors such as healthcare, life sciences, drug discovery, healthcare information management, financial services and real estate.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.